Laboratory: Clinical Biochemistry
Test Name:
PANCREATIC FLUID (Biochemistry Specimen ID: PA) - PA
Test Code: See Reference Values section below
Clinical Information:
Alternate Name(s): Pancreatic fluid collection (PFC)

                              Pancreatic juice


Description:  Pancreatic cyst neoplasms are rare and represent 10 – 15% of primary cystic masses of the pancreas. Many pancreatic masses are discovered incidentally during the work-up for abdominal pain, diarrhea and other non-specific gastrointestinal symptoms.

 

In general, classification of pancreatic cystic lesions is based on histological and radiological findings. However, biochemical analysis of cystic fluid aspirate may be of some diagnostic value. The tumor markers CEA and CA19-9 are most often used to differentiate mucinous from serous pancreatic cysts.

 

Test Approval Requirements: Any test not listed on this page must be requested as a MISCELLANEOUS fluid test and requires approval by a Clinical Biochemist prior to reporting. Ordering providers should contact the Biochemist on duty through HSC paging prior to ordering any miscellaneous tests.

 

It is strongly recommended to collect a corresponding serum sample to compare to miscellaneous fluid results.
 

For more information see:

Collection Devices:
Alternate Device: Vacutainer, Plain NO GEL NO Additive (Fluid Collection)

Quantity: 1 

Specimen Required:
Pancreatic Fluid: 2.0 mL
Pediatric Pancreatic Fluid: 2.0 mL

Collection Information: Submit to the laboratory in a sterile collection container without anticoagulant.
Referral:

Adult Volume: 2.0 mL

Pediatric Volume: 2.0 mL

Shipping & Storage: Ship refrigerated if testing cannot occur within 2 hours of collection.

Testing Laboratory (MB): Health Sciences Centre, St Boniface Hospital, and Westman lab. 

Requisition:
Reference Values:
Reference Intervals: 
Test NameTest CodeResultInterpretation
*CEACEFL>192 µg/LSuggestive of mucinous cyst
  ≤ 192 µg/LPseudocyst or serous cyst
  <5 µg/LVery low risk of mucinous cyst. 
*CA19-9C19F<37 U/mLPseudocyst or serous cyst
  ≥37 U/mLSuggestive of mucinous cyst
  >100 U/mLSuggestive of malignant etiology

 *These assays are not Health Canada approved for use in Pancreatic Fluid; method performance characteristics are unknown. Test results must be integrated into the clinical context for interpretation.

Method of Analysis: Roche cobas Pro c503

Availability:
Daily
Daily at Health Sciences Centre, St. Boniface Hospital and Westman Lab. Other locations dependent on lab shipments to reference labs.
See Also:
More Information:
Interpretation & Assay Interferences: For interpretation guidance, please see: Fluids Interpretive Guide

References: 

1. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, et al.  2004. Diagnosis of pancreatic cystic neoplasms: a report of cooperative pancreatic cyst study. Gastroenterology. 126(5):1330-1336

2. Cotten SW, Block DR. 2023. A Review of Current Practices and Future Trends in Body Fluid Testing. J Appl Lab Med. 8(5): 962-983.

3. Block DR, FLorkowski CM. “Body Fluids”, In: Rifai N, Chiu RWK, Young I, Burnham C-AD, Wittwer CT. Editors. Tietz Textbook of Laboratory Medicine. 7th Ed. Philadelphia (PA): Elsevier; 2022. pp 456.e36.

4. Elta GH, Enestvedt BK, Sauer BG, Lennon AM. 2018. ACG clinical guideline: diagnosis and management of pancreatic cysts. Am J Gastroenterol. 113(4):464-479.